FIELD: medicine.
SUBSTANCE: group of inventions relates to the field of medicine, namely to the application of Lactobacillus 8700:2 (DSM 13434) strain for the prevention and/or treatment of celiac disease autoimmunity (CDA) or for the prevention and/or treatment of celiac disease (CD) in a subject, it also relates to the application of Lactobacillus Plantarum HEAL 9 (DSM 15312) strain for the prevention and/or treatment of celiac disease autoimmunity (CDA) or for the prevention and/or treatment of celiac disease (CD) in a subject, and it also relates to the application of Lactobacillus paracasei 8700:2 (DSM 13434) strain in a combination with Lactobacillus plantarum HEAL 9 (DSM 15312) strain for the prevention and/or treatment of celiac disease autoimmunity (CDA) or for the prevention and/or treatment of celiac disease (CD) in a subject.
EFFECT: group of inventions provides alternative probiotic strains for the treatment and/or prevention of celiac disease autoimmunity (CDA) or for the treatment and/or prevention of celiac disease (CD).
12 cl, 2 dwg, 27 tbl
Authors
Dates
2021-12-28—Published
2018-01-12—Filed